आईएसएसएन: 2167-0420
Meseret W Mariam Erashi, Fekadu Yadassa Tesso and Tekleberhan Tema Beyene
Background: The sexual and reproductive health of HIV positive people is fundamental to their well-being and that of their partners and children. So the simultaneous protection against both unwanted pregnancy and STIs or dual protection is an important care core to be taken into consideration.
Method: With the objective to assess dual-contraceptive method utilization and associated factors among HIV positive women attending ART clinic in Gebretsadik Shawo Hospital a cross-sectional study was carried out using both quantitative and qualitative approaches of data collection methods on a sample of 243 HIV positive mothers selected by simple random sampling technique from 718 HIV positive women using their ART registration numbers. Data was collected through face-to-face interview using pre-tested structured questionnaire and in-depth interview for the qualitative one. The quantitative data was analyzed using SPSS-16.0; multiple logistic regression analysis was done to see the association between the outcome and predictor variables with statistical significant level of p<0.05 and CI of 95%. For qualitative study 18 purposively selected community mother support HIV positive mothers were included and data was analyzed thematically.
Result: Out of 246, 243 of HIV positive women participated in the study making a response rate of 98.78%. The study finding showed that the prevalence of dual contraceptive use by HIV positive women attending ART clinic was 48(19.8%). A multivariate Logistic regression analysis showed that the dual contraceptive family planning method utilization was associated with age [(age > 30 years women were more likely to use dual contraceptives than those of age group 15-24 years [(AOR 2.445, 95% CI (1.131, 5.284)], marital status [widowed women were more likely to use dual contraceptive method than married ones (AOR 4.018, 95% CI(1.219, 13.21)], CD4 count [women with CD4 count greater than 350 cells/dl were more likely to use dual contraceptive methods than those with CD4 count <250 cells/ dl [(AOR 8.516, 95% CI (1.005, 72.168)], and free discussion with partners and deciding on contraceptive method were more likely to use dual contraceptive methods than those who don’t have open discussion, [(AOR 17.45, 95% CI(8.198, 37.14)].
Conclusion: Dual contraception utilization by HIV positive women was very low and advanced age, CD4 count, discussion with partners, residence, counseling, were associated with dual contraceptive use by HIV positive women. Use of dual contraceptive methods utilization is a vital core in prevention of HIV infection in children and transmissions of new HIV strains among HIV positive population.